Navigation Links
Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
Date:10/1/2007

Delsym is the only FDA-approved 12-hour non-prescription liquid cough

suppressant

CHESTER, N.J., Oct. 1 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. (Nasdaq: ARxT) today announced that the Food and Drug Administration (FDA) approved its supplemental New Drug Application for a grape-flavored formulation of Delsym Extended-Release Suspension on Friday, Sept. 28, 2007. The Company will immediately commence distribution of grape Delsym product to its trade customers.

Delsym is the first and only over-the-counter (OTC) liquid that controls cough for a full 12 hours with a single dose, providing all day or all night cough suppression with each dose. Delsym's patented single-ingredient formula delivers great tasting medicine in orange and now new grape flavors for both children and adults.

About Adams Respiratory Therapeutics, Inc.

Adams is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.


'/>"/>
SOURCE Adams Respiratory Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Passive smoking affects respiratory system
2. Occupational exposurer aises respiratory symptoms
3. Severe Acute respiratory Syndrome (SARS)
4. WHO Travel Advice to prevent spread of "Severe Acute Respiratory Syndrome (SARS)
5. Good News for New Borns With Hypoxic Respiratory Failure
6. Understanding The Link Between Hormone Replacement and Respiratory Disease
7. Hand sanitizers may reduce respiratory and gastrointestinal infections at home
8. Antibiotics for acute uncomplicated lower respiratory tract infection
9. Handwashing prevents diarrhea and acute lower respiratory infections
10. New Virus Held Responsible For Respiratory Infection In Children
11. Second Hand Exposure To Smoke In Childhood Can Cause Respiratory Problems Later

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Biotech firm Replikins Ltd. today issu...us genomic data. It shows that the lethality of t...5) during the virus,s current outbreak in the spri...k of 2.0 (s.d. 0.1). The H1N1 infectivity count, h... Boston (PRWEB) November 27, 2009 -- Biotech fi...
(Date:11/27/2009)...TER,N.Y.,Nov.27/PRNewswire-USNewswire/--Preventing...atelyeveryyear,newvaccinesarebeingaddedtoassistind...hesameperiodoftime?And,ifnot,whenareadditional,boo...month,sissueofPediatrics,theJournaloftheAmericanAc...eRochesterGeneralResearchInstitute,basedatRocheste...
(Date:11/27/2009)... XenaCare Holdings has announced that i...oundation, one of the largest nonprofit organizati...lth education. , Delray B...dings, Inc. (OTCBB: XCHO), a company specializing ...er healthcare products, has announced today that i...
(Date:11/27/2009)...E,Nov.27/PRNewswire/-- Allrecipes.com , theworld,...numbers,withmorethan2.8millionvisitorsthedaybefore...onthebiggestfoodholidayoftheyear.TheaverageThanksg...a5percentincreasefromlastyear,sfeast.Accordingtoth...mostpopularThanksgivingrecipe,acontrastfromlastyea...
(Date:11/27/2009)... Specialist manufacturers who use medic...aving millions of dollars by bringing in technolog...reasing numbers of pro-active medical manufacturer...concept stage of their projects, ensuring that pro...rocesses or potentially outdated technology. , ...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
... Inc.,(Nasdaq: OMCL ) a leading provider of syste... and operational efficiency in healthcare,faciliti...n, president &,CEO and Rob Seim, vice president & ...0 a.m. Eastern Time. A live audio-webcast of the ...
...sued,today by Active Minds, Inc.: WHO: Alison Mal... Inc. WHAT: Ms. Malmon is available to comment on..., including depression and suicide Ms. Malmon is ...ollege students. Alison founded Active Minds,the o...
... Inc.,(NYSE: CSA ) announced this afternoon that ... II in Brunswick, Georgia for approximately $24.8,...7,472 square feet and is,98 percent leased. This ...are system, is the anchor tenant and currently lea...
...sident and CEO of Yakima Neighborhood Health Servi...hair-Elect of the National Association of,Communit...Convention and,Community Health Institute (CHI) in..., "I am so excited to have the support of my coll...
...gs in Italian study , , THURSDAY, Aug. 30 ...aking cholesterol-lowering statins doubled their r...o stayed on the medications, an Italian study find...es on the heels of a Spanish study that found disc...
...s may happen more frequently than thought, study s...scovery of an entire genome from one species insid... new research suggests. , Writing in the Aug. 30...velop new cellular functions more rapidly. , "The...
Other Medicine News:Health News:Omnicell to Present at Thomas Weisel Healthcare Conference 2007 2Health News:College Mental Health Expert and Sister of Student Who Died By Suicide Available to Discuss College Mental Health Issues 2Health News:Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia 2Health News:Yakima Health Care Leader Tapped for Leadership Post at National Association 2Health News:Stopping Statins After Stroke Doubles Death Risk 2Health News:Stopping Statins After Stroke Doubles Death Risk 3Health News:One Species' Genome Found Within Another 2
(Date:11/25/2009)...Asia-FirstCall/--ChinaSkyOne,Medical,Inc.("ChinaSk...ngfullyintegratedpharmaceuticalcompanydevelopingan...licofChina("PRC"),today,announcedthattheCompanyrec...olofPharmaceuticalandBiologicalProducts("ICPBP")ex...orHumanProstateSpecific,Antigen(ColloidalGold)andi...
(Date:11/25/2009).../--AccordingtoMillenniumResearchGroup(MRG),theglob...henearly$3billionUSmarketfortraumafixationdevicesw...pitetherecenteconomicslowdown.MRG,s USMarketsforTr...ainhighlydynamicoverthenextfiveyears,withcompetito...rvedsegmentsofthetraumafixationmarket,fuelingmarke...
(Date:11/25/2009)...BURG,November25/PRNewswire/--,iThembaPharmaceutica...thattheyhavesignedacollaborativeagreementtojointly...classcomputationalchemistryandleaddiscoveryexperti...idemedicinaland,syntheticchemistrysupporttoproject...k.iThembaPharmaceuticalsandPyxisDiscovery,alsoanno...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Harvest Technologies Announces Completion of Patient Enrollment in its Randomized Controlled Double Blind Multicenter IDE Non Reconstructable Critic 14772 1Harvest Technologies Announces Completion of Patient Enrollment in its Randomized Controlled Double Blind Multicenter IDE Non Reconstructable Critic 14772 2Facet Solutions Enrolls 100th Patient in US Pivotal IDE Study 6113 1Facet Solutions Enrolls 100th Patient in US Pivotal IDE Study 6113 2Hill Rom and Encompass Group Form Joint Venture 6110 1Hill Rom and Encompass Group Form Joint Venture 6110 2Hill Rom and Encompass Group Form Joint Venture 6110 3Hill Rom and Encompass Group Form Joint Venture 6110 4Hill Rom and Encompass Group Form Joint Venture 6110 5
Vectograms®
Vectographic Slide 9300
Vectographic Slide 9200
Projector Slide 8800
Medicine Products: